From the UCLA press release: Head injuries can harm hundreds of genes in the brain in a way that increases people’s risk for a wide range of neurological and psychiatric disorders, UCLA life scientists report.…
From the IOS Press press release: The patient is a retired teacher who had reported memory difficulties 12 months prior to the study. These difficulties referred to trouble remembering names and groceries she wanted to…
From the IOS Press press release: Greek researchers demonstrated the potential of a self-administered virtual supermarket cognitive training game for remotely detecting mild cognitive impairment (MCI), without the need for an examiner, among a sample…
From the University of Eastern Finland media release: The use of benzodiazepines and benzodiazepine-like drugs was associated with a 20 per cent increased risk of stroke among persons with Alzheimer’s disease, shows a recent study from…
From the Medical University of South Carolina media release: Evidence overwhelmingly supports a link between cognitive decline and cerebrovascular diseases such as atherosclerosis, arteriolosclerosis, and cerebral amyloid angiopathy. Not only do individuals with cerebrovascular diseases have…
From the Public Health Ontario media release: People who live close to high-traffic roadways face a higher risk of developing dementia than those who live further away, new research from Public Health Ontario (PHO) and…
From the American Academy of Neurology (AAN) media release: A new study shows that older people who followed a Mediterranean diet retained more brain volume over a three-year period than those who did not follow…
From the McLean Hospital media release: A new pilot study led by McLean Hospital’s Ipsit Vahia, MD, medical director of Geriatric Psychiatry Outpatient Services at McLean Hospital, suggests that the use of tablet computers is both a…
From the Karolinska Institutet media release: So far, many of the antibody drugs proposed to treat Alzheimer’s disease target only the amyloid plaques. Despite the latest clinical trial that is hailed as our best chance in the…
From the University of Eastern Finland media release: Approximately seven per cent of persons with Alzheimer’s disease use strong pain medicines, opioids, for non-cancer pain for a period longer than six months, according to a recent study…